"10.1371_journal.pone.0092146","plos one","2014-03-20T00:00:00Z","Joost C M Uitdehaag; Jeroen A D M de Roos; Antoon M van Doornmalen; Martine B W Prinsen; Jos de Man; Yoshinori Tanizawa; Yusuke Kawase; Kohichiro Yoshino; Rogier C Buijsman; Guido J R Zaman","Netherlands Translational Research Center B.V., Oss, The Netherlands; Carna Biosciences Inc., Kobe, Japan","Conceived and designed the experiments: JCMU JADMDR RCB GJRZ. Performed the experiments: JCMU JADMDR AMVD MBWP. Analyzed the data: JCMU JADMDR YT YK RCB GJRZ. Contributed reagents/materials/analysis tools: JDM KY. Wrote the paper: JCMU GJRZ.","RB and GZ are founders and shareholders of Netherlands Translational Research Center B.V. (NTRC). KY is a founder of Carna Biosciences, Inc. (Carna). KY and YK are shareholders of Carna. The described cancer cell line profiling is offered as a commercial service by NTRC under the brand name Oncolines. The described biochemical kinase profiling is offered as a commercial service by Carna under the brand name QuickScout. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","03","Joost C M Uitdehaag","JCMU",10,TRUE,4,4,6,2,TRUE,TRUE,FALSE,0,NA,FALSE
